Charles

  • Charles River selects BRASS to market biopharmaceutical services in Singapore

    Charles River announces that it has entered into a marketing agreement with Singapore-based Biomedical Research And Support Services Pte. Ltd (BRASS). Through the agreement, BRASS will market within Singapore, Malaysia, Indonesia, and Vietnam the wor…

    Charles | 15 August 2011

  • Charles River to Merge with Wuxi

    Charles River Laboratories International and WuXi PharmaTech (Cayman) have signed an agreement under which the companies will combine in a cash and stock transaction valued at approximately US$1.6 billion. The combined company, which will retain …

    Charles | 21 May 2010